{"url_path":"/sec/bblg/8-k/2026-07-09/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ****Other","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/1419554/0001493152-26-032694-index.html","accession_number":"0001493152-26-032694","cik":"0001419554","ticker":"BBLG","issuer_name":"Bone Biologics Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1419554/0001493152-26-032694-index.html","primary_entity_key":"0001419554","primary_entity_name":"Bone Biologics Corp"},"word_count":46,"has_tables":true,"body_markdown":"** **\n\n**Item 8.01****Other\nEvents.**\n\n** **\n\nOn\nJuly 7, 2026, the Company issued a press release announcing that the Company had priced the Offering. A copy of the press release is\nattached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein."}